1617-37-4 Usage
General Description
(Z)-2-methylpent-2-enoic acid, also known as (Z)-2-methyl-2-pentenoic acid, is an organic compound with the chemical formula C6H10O2. It is a carboxylic acid, containing a double bond in the second carbon and a methyl group in the second position. (Z)-2-methylpent-2-enoic acid is often used in the synthesis of various pharmaceuticals and agrochemicals. It is also known for its fruity odor and is commonly found in various fruits. (Z)-2-methylpent-2-enoic acid is used as a flavoring agent in the food and beverage industry and is considered safe for consumption in small amounts. Overall, this compound has several industrial and commercial applications, making it a valuable chemical in various sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 1617-37-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,1 and 7 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1617-37:
(6*1)+(5*6)+(4*1)+(3*7)+(2*3)+(1*7)=74
74 % 10 = 4
So 1617-37-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H10O2/c1-3-4-5(2)6(7)8/h4H,3H2,1-2H3,(H,7,8)/b5-4-
1617-37-4Relevant articles and documents
-
Bergel'son,L.D. et al.
, (1962)
-
Structure-activity relationships of unsaturated analogues of valproic acid
Palaty,Abbott
, p. 3398 - 3406 (2007/10/02)
The principal metabolite of valproic acid (VPA), 2-ene VPA, appears to share most of VPA's pharmacological and therapeutic properties while lacking its hepatotoxicity and teratogenicity, thus making it a useful lead compound for the development of safer antiepileptic drugs. Analogues of 2-ene VPA were evaluated for anticonvulsant activity in mice using the subcutaneous pentylenetetrazole test. Cyclooctylideneacetic acid exhibited a potency markedly exceeding that of VPA itself with only modest levels of sedation. Potency, as either ED50 or brain concentration, was highly correlated (r > 0.85) with volume and lipophilicity rather than with one of the shape parameters calculated by molecular modeling techniques, arguing against the existence of a specific receptor site. Instead, a role for the plasma membrane in mediating the anticonvulsant effect is suggested.
